Australian woman’s untimely demise connected to widely used weight loss medication, Ozempic

The death of 56-year-old Australian woman Trish Webster has been linked to the widely popular weight loss drug Ozempic, according to multiple reports. Trish’s weight loss journey, motivated a desire to shed a few kilograms before her daughter’s wedding, ended tragically, raising concerns about the safety of Ozempic and similar medications.

Trish’s husband, Roy Webster, shared the heartbreaking details of her weight loss journey on 60 Minutes Australia. After turning to Ozempic and Saxenda for weight loss, Trish faced severe side effects, including nausea and diarrhea, despite losing 16 kilograms. Her husband found her unconscious on January 16, 2023, with a little brown liquid coming from her mouth. Despite efforts, Trish passed away that night, her death certificate attributing it to acute gastrointestinal illness.

Ozempic’s popularity, endorsed celebrities like Elon Musk and Amy Schumer, has led to a global shortage of the drug. Regulatory warnings and FDA product updates have acknowledged reports of complications related to Ozempic’s usage. Manufacturer Novo Nordisk stands behind the drug’s safety, while legal actions against the company are underway in the US. Endocrinologist Dr. Kathryn Williams has advised caution among users.

Devastated his wife’s death, Roy Webster is pushing for an official investigation and emphasizing the need for awareness and caution regarding the potential risks associated with weight loss drugs. He echoes the sentiments of those who have faced unexpected consequences while pursuing weight loss.

For the latest updates on this story and related articles, stay posted here at Tech Times.

Related Post